GILBERT S OMENN
CIK 1184227 · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$70.63M
Companies
8
Total Filings
91
Lifetime Open-Market Net
-$2.88M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AMST | Director | 143,699 | $0.95 | $136.5K | $128.8K | 27 | 2026-07-01 |
| GALT | Director | 66,769 | $3.39 | $226.3K | -$37.1K | 12 | 2026-01-21 |
| Elicio Therapeutics, Inc. (ANGN) Delisted | Director | 6,554 | $10.00 | $65.5K | $0 | 3 | 2022-06-13 |
| ESPR | Director | 11,000 | $3.18 | $35.0K | $218.7K | 7 | 2017-04-19 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | Director | 67,561 | — | — | $0 | 3 | 2016-12-19 |
| AMGN | Director | 178,669 | $393.10 | $70.23M | -$3.19M | 19 | 2013-04-30 |
| ROHM & HAAS CO (ROH) Delisted | Director | 50,149 | — | — | $0 | 14 | 2009-03-04 |
| TearLab Corp (OCCX) Delisted | Director | — | — | — | $0 | 4 | 2007-07-05 |
Recent Filings · Page 3 of 10
91 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-01-03 | AMST | Grant (A) | — | $0 | EDGAR |
| 2023-10-03 | AMST | Grant (A) | — | $0 | EDGAR |
| 2023-07-05 | AMST | Grant (A) | — | $0 | EDGAR |
| 2023-04-04 | AMST | Grant (A) | — | $0 | EDGAR |
| 2023-01-30 | GALT | Grant (A) | — | $0 | EDGAR |
| 2023-01-05 | AMST | Grant (A) | — | $0 | EDGAR |
| 2022-10-03 | AMST | Grant (A) | — | $0 | EDGAR |
| 2022-07-05 | AMST | Grant (A) | — | $0 | EDGAR |
| 2022-07-05 | AMST | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | Elicio Therapeutics, Inc. (ANGN) Delisted | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.